Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Submitted by
admin
on September 17, 2012 - 10:51am
Source:
Yahoo/Fly on the Wall
News Tags:
Regeneron
Eylea
central retinal vein occlusion
Headline:
Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Do Not Allow Advertisers to Use My Personal information
